| 摘要 |
<p>This invention relates to methods of using genotyping to select patients for treatment with compounds capable of elevating ketone body concentrations in amounts effective to treat reduced cognitive function associated with reduced neuronal metabolism, for example Alzheimer's disease.</p> |
